FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

被引:111
作者
Ahmadzadeh, Mojgan [1 ]
Felipe-Silva, Aloisio [2 ]
Heemskerk, Bianca [1 ]
Powell, Daniel J., Jr. [1 ]
Wunderlich, John R. [1 ]
Merino, Maria J. [2 ]
Rosenberg, Steven A. [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2008-06-163048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulatory T(T-reg) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T-reg cell populations. Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T-reg cells from effector T cells. Similar to T-reg cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3 + CD4 T cells, unlike FOXP3 + T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T-reg cells even in the tumor microenvironment. Accordingly, we enumerated FOXP3 + CD4 T-reg cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3 + CD4 T-reg cells in the intratumoral compared with peritumoral areas. Moreover, their frequencies were 3-to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively. These findings demonstrate that the tumor-infiltrating CD4 T-reg cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment. (Blood. 2008; 112: 4953-4960)
引用
收藏
页码:4953 / 4960
页数:8
相关论文
共 45 条
[1]   IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients [J].
Ahmadzadeh, M ;
Rosenberg, ST .
BLOOD, 2006, 107 (06) :2409-2414
[2]   IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells [J].
Ahmadzadeh, Mojgan ;
Antony, Paul A. ;
Rosenberg, Steven A. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (03) :294-302
[3]   CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells [J].
Antony, PA ;
Piccirillo, CA ;
Akpinarli, A ;
Finkelstein, SE ;
Speiss, PJ ;
Surman, DR ;
Palmer, DC ;
Chan, CC ;
Klebanoff, CA ;
Overwijk, WW ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2591-2601
[4]   Interleukin 2-dependent mechanisms of tolerance and immunity in vivo [J].
Antony, Paul A. ;
Paulos, Chrystal M. ;
Ahmadzadeh, Mojgan ;
Akpinarli, Akgul ;
Palmer, Douglas C. ;
Sato, Noriko ;
Kaiser, Andrew ;
Heinrichs, Christian ;
Klebanoff, Christopher A. ;
Tagaya, Yutaka ;
Restifo, Nicholas P. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (09) :5255-5266
[5]   Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma [J].
Attia, P ;
Maker, AV ;
Haworth, LR ;
Rogers-Freezer, L ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) :582-592
[6]   Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[7]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[8]   TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs [J].
Bisikirska, B ;
Colgan, J ;
Luban, J ;
Bluestone, JA ;
Herold, KC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2904-2913
[9]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[10]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949